Grail Inc (GRAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRAL | IMVT | ARQT | ||
| Company | Grail Inc | Immunovant Inc | Arcutis Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 105.00 | 22.89 | 31.03 | ||
| High | 105.00 | 23.12 | 31.45 | ||
| Low | 99.39 | 22.58 | 30.39 | ||
| Latest | 100.98 | 22.84 | 31.20 | ||
| Change | -3.72 | -0.07 | +0.04 | ||
| % Change | -3.56% | -0.31% | +0.13% | ||
| Volume | 503,800 | 829,500 | 1,284,700 | ||
| 20-Day Average Volume | 1,192,455 | 1,297,605 | 2,460,765 | ||
| Previous Close | 104.71 | 22.91 | 31.16 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 93.56 | 23.22 | 27.83 | ||
| 20-Day Raw Stochastic | 64.61% | 41.47% | 97.28% | ||
| 20-Day Relative Strength | 58.41 | 54.98 | 69.91 | ||
| Weighted Alpha | +167.25 | -9.98 | +177.90 | ||
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.52% since 11/28/25 | -5.42% since 11/28/25 | +1.79% since 11/28/25 | ||
| Low | 93.34 on 12/03/25 | 21.93 on 12/02/25 | 28.95 on 12/02/25 | ||
| High | 108.00 on 12/01/25 | 24.14 on 12/01/25 | 31.45 on 12/05/25 | ||
| 1-Month | |||||
| %Chg | +19.31% since 11/05/25 | -3.22% since 11/05/25 | +27.97% since 11/05/25 | ||
| Low | 74.00 on 11/07/25 | 21.43 on 11/10/25 | 22.26 on 11/14/25 | ||
| High | 115.76 on 11/25/25 | 24.83 on 11/14/25 | 31.45 on 12/05/25 | ||
| 3-Month | |||||
| %Chg | +173.58% since 09/05/25 | +33.26% since 09/05/25 | +81.92% since 09/05/25 | ||
| Low | 35.39 on 09/10/25 | 14.58 on 09/22/25 | 16.57 on 09/25/25 | ||
| High | 115.76 on 11/25/25 | 26.17 on 10/30/25 | 31.45 on 12/05/25 | ||
| 6-Month | |||||
| %Chg | +155.71% since 06/05/25 | +42.57% since 06/05/25 | +130.94% since 06/05/25 | ||
| Low | 29.95 on 08/20/25 | 14.32 on 08/11/25 | 12.72 on 06/13/25 | ||
| High | 115.76 on 11/25/25 | 26.17 on 10/30/25 | 31.45 on 12/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,936,402 | 4,003,327 | 3,821,750 | ||
| Shares Outstanding, K | 38,982 | 175,277 | 122,492 | ||
| Annual Sales | 125,600,000 | 0 | 196,540,000 | ||
| Annual Net Income | -2,027,010,000 | -413,840,000 | -140,040,000 | ||
| Last Quarter Sales | 36,190,000 | 0 | 99,220,000 | ||
| Last Quarter Net Income | -88,980,000 | -126,500,000 | 7,410,000 | ||
| 60-Month Beta | 4.23 | 0.56 | 1.69 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.46 on 11/12/25 | -0.73 on 11/10/25 | 0.06 on 10/28/25 | ||
| Latest Earnings Date | 11/12/25 | 11/10/25 | 10/28/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||